InvestorsHub Logo
Followers 23
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Re: Buyfor1sell for2 post# 141990

Monday, 06/15/2020 9:03:37 AM

Monday, June 15, 2020 9:03:37 AM

Post# of 182970
ADMP Adamis Pharmaceuticals Announces License to Commercialize Tempol, a Novel Investigational Anti-inflammatory and Antioxidant Drug for the Treatment of Respiratory Diseases Including COVID-19

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.